相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative Proteomic Phenotyping of Cell Lines and Primary Cells to Assess Preservation of Cell Type-specific Functions
Cuiping Pan et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Global and Site-Specific Quantitative Phosphoproteomics: Principles and Applications
Boris Macek et al.
Annual Review of Pharmacology and Toxicology (2008)
From Single- to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage
S. Giordano et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Transcriptional profiling defines the roles of ERK and p38 kinases in epidermal keratinocytes
Alix Gazel et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Identification of dominant signaling pathways from proteomics expression data
Roman A. Zubarev et al.
JOURNAL OF PROTEOMICS (2008)
Phosphoproteomics: Unraveling the signaling web
Paul H. Huang et al.
MOLECULAR CELL (2008)
Combined use of RNAi and quantitative proteomics to study gene function in Drosophila
Tiziana Bonaldi et al.
MOLECULAR CELL (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Quantitative phosphoproteome analysis of a mouse liver cell line reveals specificity of phosphatase inhibitors
Cuiping Pan et al.
PROTEOMICS (2008)
High-content single-cell drug screening with phosphospecific flow cytometry
Peter O. Krutzik et al.
NATURE CHEMICAL BIOLOGY (2008)
Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins
Johannes Graumann et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Dasatinib: A tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
Michael Steinberg
CLINICAL THERAPEUTICS (2007)
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Jayne M. Stommel et al.
SCIENCE (2007)
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2007)
The Btk tyrosine kinase is a major target of the Bcr-Abi inhibitor dasatinib
Oliver Hantschel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Is proteomics the new genomics?
Juergen Cox et al.
CELL (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia
Ellen Weisberg et al.
NATURE REVIEWS CANCER (2007)
The serine/threonine/tyrosine phosphoproteome of the model bacterium Bacillus subtilis
Boris Macek et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Cell-cycle-dependent phosphorylation of the nuclear pore Nup107-160 subcomplex
Joseph S. Glavy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Small-molecule screening: Advances in microarraying and cell-imaging technologies
Rebecca L. Nicholson et al.
ACS CHEMICAL BIOLOGY (2007)
STRING 7 - recent developments in the integration and prediction of protein interactions
Christian von Mering et al.
NUCLEIC ACIDS RESEARCH (2007)
Functional and quantitative proteomics using SILAC
Matthias Mann
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks
Jesper V. Olsen et al.
CELL (2006)
MAPK signalling: ERK5 versus ERK1/2
Satoko Nishimoto et al.
EMBO REPORTS (2006)
Phosphoproteomic analysis of Her2/neu signaling and inhibition
Ron Bose et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A common phosphotyrosine signature for the Bcr-Abl kinase
Valerie L. Goss et al.
BLOOD (2006)
Cellular imaging in drug discovery
P Lang et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions
S Yoon et al.
GROWTH FACTORS (2006)
Cytomics as a new potential for drug discovery
Guenter Valet
DRUG DISCOVERY TODAY (2006)
Status of complete proteome analysis by mass spectrometry: SILAC labeled yeast as a model system
Lyris M. F. de Godoy et al.
GENOME BIOLOGY (2006)
Regulation of cellular functions by the ERK5 signalling pathway
X Wang et al.
CELLULAR SIGNALLING (2006)
Characterisation of kinase-selective inhibitors by chemical proteomics
H Daub
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Parts per million mass accuracy on an orbitrap mass spectrometer via lock mass injection into a C-trap
JV Olsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases
TA Carter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns
MR Larsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants
T O'Hare et al.
CANCER RESEARCH (2005)
Features of selective kinase inhibitors
ZA Knight et al.
CHEMISTRY & BIOLOGY (2005)
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
W Pao et al.
PLOS MEDICINE (2005)
Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway
A Gruhler et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
A small molecule-kinase interaction map for clinical kinase inhibitors
MA Fabian et al.
NATURE BIOTECHNOLOGY (2005)
Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2
S Morton et al.
FEBS LETTERS (2004)
Discovery of N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays
LJ Lombardo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-nanoLC-ESI-MS/MS and titanium oxide precolumns
MWH Pinkse et al.
ANALYTICAL CHEMISTRY (2004)
A neutral loss activation method for improved phosphopeptide sequence analysis by quadrupole ion trap mass spectrometry
MJ Schroeder et al.
ANALYTICAL CHEMISTRY (2004)
Trypsin cleaves exclusively C-terminal to arginine and lysine residues
JV Olsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
The specificities of protein kinase inhibitors: an update
J Bain et al.
BIOCHEMICAL JOURNAL (2003)
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
GL Johnson et al.
SCIENCE (2002)
Glivec (ST1571, Imatinib), a rationally developed, targeted anticancer drug
R Capdeville et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics
SE Ong et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Protein kinases - the major drug targets of the twenty-first century?
P Cohen
NATURE REVIEWS DRUG DISCOVERY (2002)
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
SB Ficarro et al.
NATURE BIOTECHNOLOGY (2002)
Specificity and mechanism of action of some commonly used protein kinase inhibitors
SP Davies et al.
BIOCHEMICAL JOURNAL (2000)
STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene
B Snel et al.
NUCLEIC ACIDS RESEARCH (2000)
ZD1839 ('Iressa')(1,2) as an anticancer agent
J Baselga et al.
DRUGS (2000)
分享论文
